Reducing Medicare Part D drug prices requires careful tools, not simply the power to negotiate
Read More...
Read the complete post at http://healthaffairs.org/blog/2010/04/08/medicare-part-d-drug-pricing/
Posted
Apr 08 2010, 11:55 AM
by
Health Affairs Blog
Filed under: Blog, Policy, Health Care Costs, Uncategorized, Medicare, Pharma, Cost, Health Law, part d, Biotech, drug, pricing